1. |
2023
Chang CY,Chiou SS,Weng TF,Lin PC,Lai SW,Tsai CH.
Clinical Predictors and Prediction Models for rFVIII-Fc Half-Life in Real-World People With Severe Hemophilia A.
. JCM
.2023
|
|
2. |
2023
Teng WJ,Kung CH,Cheng MM,Tsai JR,Chang CY.
Intramural Hematoma of Gastrointestinal Tract in People With Hemophilia A and B.
. JCM
.2023
|
|
3. |
2023
Srivastava A,Rangarajan S,Kavakli K,Klamroth R,Kenet G,Khoo L.
Efficacy and safety of fitusiran prophylaxis in people with severe haemophilia A or B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised Phase 3 trial.
. Lancet Haematol
.2023
|
|
4. |
2023
Huang JH,Chen SH, Liao YM,Kao YC,Ho WL,Chang H.
Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma.
. JPM
.2023
;(13):668
|
|
5. |
2022
Chien TC,Chien MM,Liu TL,Chang H,Tsai ML,Tseng SH.
Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma
. Children
.2022
|
|
6. |
2022
Liu YL, Tsai ML,Chen CI,Yar N,Tsai CW,Lee HL.
Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study.
. Cancers (Basel)
.2022
;(14):668
|
|
7. |
2022
Chien TC,Chien MM,Liu TL, Chang H,Tsai ML,Tseng SH.
Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma
. Children (Basel)
.2022
|
|
8. |
2022
Liu YL,Tsai ML,Chen CI,Yar N,Tsai CW, Lee HL.
Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study
. Cancers
.2022
|
|
9. |
2022
Chen YC,Chang CY,Cheng SN,Pan RY , Shih YL,Li TY.
Evolution of congenital haemophilia care in Taiwan
. J Formos Med Assoc
.2022
|
|
10. |
2022
Lai SW, Chang CY,Cheng SN,Hu SH,Lai CY, Chen YC.
A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
. Int J Gen Med
.2022
|
|
11. |
2022
Chang CY, Lai SW,Cheng MM,Ku JT, Hu SH,Liu YL.
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy.
. Int J Hematol
.2022
|
|
12. |
2020
Lin TC,Chen SH,Wu CC,Chang CY.
Successful Bleeding Control of Refractory Hemothorax in Two Hemophilia A Patients with High-Titer Inhibitors.
. Pediatr Neonatol
.2020
;(61):361-363
|
|
13. |
2019
Tsai JR,Lin CY,Cheng MM,Chang CY.
Successful Treatment of Refractory Pancreatic Hemorrhage and Pseudoaneurysm Related to Chronic Pancreatitis in a Patient with Severe-Type Hemophilia A.
. KJMS
.2019
;(35):448-449
|
|
14. |
2019
Chang CY,Perng CL,Cheng SN,Hu SH,Wu TY,「Lin SY」、「Chen YC」.
Deep Intronic Variant of c.5999-299G>A May Be a Hot-Spot Mutation for Mild Hemophilia A Patients Without Found DNA Mutation.
. Eur J Haemotol
.2019
;(103):47-55
|
|
15. |
2019
Chang CY,Li TY,Cheng SN,Pan RY,Cheng CN,Wang HJ, Hu SH, 「Chen YC」.
Obesity and Overweight in Patients with Hemophilia:Prevalence by Age, Clinical Correlates, and Impact on Joint Bleeding.
. J Chin Med Assoc
.2019
;(82):289-294
|
|
16. |
2017
Chang CY,Li TY,Cheng SN,Pan RY,Wang HJ,「Lin SY」、「Chen YC」.
Prevalence and Severity by Age and Other Clinical Correlates of Haemophilic Arthropathy of the Elbow, Knee, and Ankle among Taiwanese Patients With Haemophilia.
. Haemophilia
.2017
;(23):284-291
|
|
17. |
2016
Chang CY,Lin SY,Tsai JR,Tsai CH,Chen YC.
Successful Multivessel Percutaneous Coronary Intervention for Acute Coronary Syndrome in a HIV-positive Severe Hemophiliac.
. Haemophilia
.2016
;(22):e481-e484
|
|
18. |
2016
Yen TL,Wu MP,Chung CL,Yang WB,Jayakumar,「Geraldine P」,「Chou CM」,「Chang CY」,「Lu WJ」, 「Sheu JR」.
Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism.
. J Biomed Sci
.2016
;(23):1-13
|
|